-The Hindu The lawsuit by publishers seeking to stop Delhi University from distributing photocopied course packs goes against the spirit of education for all Late last year, leading publishing houses including Oxford University Press and Cambridge University Press brought a copyright action against Delhi University and a tiny photocopy shop licensed by it, seeking to restrain them from supplying educational course packs to students. This lawsuit sent shock waves across the...

-Live Mint Government rejects coal price pooling, moves closer to allowing projects assured fuel linkages by CIL to import coal The government rejected a proposal to pool coal prices and instead moved a step closer to allowing power projects that had been awarded through competitive bidding and assured fuel linkages by state-owned miner Coal India Ltd (CIL) to import the fuel and pass on the incremental costs as higher electricity tariffs. Price pooling...

-The Hindu The UPA government has been proactive in responding to demands by Reliance Industries Limited (RIL) for a raise in natural gas prices, but has shown little urgency in implementing the Comptroller and Auditor General's (CAGs) recommendations made in 2009 on the audit of oil and gas contractors such as RIL. The CAG recommendation would have facilitated the intense scrutiny of the prices and profits made by the contractors. The Petroleum Ministry's...

-The Times of India Prime Minister Manmohan Singh has been given a clean chit by the Joint Parliamentary Committee on telecom which rubbished CAG's Rs 1.76 lakh crore loss calculations in the 2G scam but slammed the Vajpayee government for Rs 40,080 crore loss due to a policy shift in 1999. The committee - headed by Congress MP P C Chacko - in its draft report pinned the 2G blame on former...

-The Hindu     Drug patents are designed to create profits that enable more research on diseases affecting millions. But in practice, they have often generated super profits for big pharma companies while erecting access barriers for the poor. The Novartis case spotlights much that is wrong with the system. The rejection of the Novartis petition challenging one of the most progressive tenets of the Indian Patents Act (1970), as amended in 2005 by...